Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS

Table of Contents

June 01, 2004; Volume 31,Issue 6
  • You have access
    Is there a rationale for switching from one anti-tumor necrosis factor agent to another?
    Boulos Haraoui
    The Journal of Rheumatology June 1 2004, 31 (6) 1021-1022;
  • You have access
    Rheumatoid arthritis: is the disease becoming milder or is treatment improving?
    Shahin Walji and Vivian P Bykerk
    The Journal of Rheumatology June 1 2004, 31 (6) 1023-1025;
  • You have access
    Measuring patient health status in rheumatoid arthritis -- what is a minimal clinically important difference?
    Stephen Brealey
    The Journal of Rheumatology June 1 2004, 31 (6) 1026-1028;
  • You have access
    What I would like to know about leflunomide.
    Joel M Kremer
    The Journal of Rheumatology June 1 2004, 31 (6) 1029-1031;
  • You have access
    Coping with chronic pain: what can we learn from pain self-efficacy beliefs?
    Doug Saunders
    The Journal of Rheumatology June 1 2004, 31 (6) 1032-1034;
  • You have access
    Hypertension, NSAID, and lessons learned.
    Janet E Pope
    The Journal of Rheumatology June 1 2004, 31 (6) 1035-1037;
  • You have access
    Activation of synovial cell p38 MAP kinase by macrophage migration inhibitory factor.
    Leilani L Santos, Derek Lacey, Yuanhang Yang, Michelle Leech and Eric F Morand
    The Journal of Rheumatology June 1 2004, 31 (6) 1038-1043;
  • You have access
    Expression of tristetraprolin (G0S24) mRNA, a regulator of tumor necrosis factor-alpha production, in synovial tissues of patients with rheumatoid arthritis.
    Akito Tsutsumi, Eiji Suzuki, Yoshihiro Adachi, Hideyuki Murata, Daisuke Goto, Satoshi Kojo, Isao Matsumoto, Lei Zhong, Hiroshi Nakamura and Takayuki Sumida
    The Journal of Rheumatology June 1 2004, 31 (6) 1044-1049;
  • You have access
    Radiographic hand joint space width assessed by computer is a sensitive measure of change in early rheumatoid arthritis.
    Jane Angwin, Andrew Lloyd, Geoff Heald, Gerald Nepom, Michael Binks and Michael F James
    The Journal of Rheumatology June 1 2004, 31 (6) 1050-1061;
  • You have access
    Variability of precision in scoring radiographic abnormalities in rheumatoid arthritis by experienced readers.
    John T Sharp, Frederick Wolfe, Marissa Lassere, Maarten Boers, Désirée Van Der Heijde, Arvi Larsen, Harold Paulus, Rolf Rau and Vibeke Strand
    The Journal of Rheumatology June 1 2004, 31 (6) 1062-1072;
  • You have access
    Radiographic progression is getting milder in patients with early rheumatoid arthritis. Results of 3 cohorts over 5 years.
    Tuulikki Sokka, Hannu Kautiainen, Arja Häkkinen and Pekka Hannonen
    The Journal of Rheumatology June 1 2004, 31 (6) 1073-1082;
  • You have access
    Effects of high dose methylprednisolone pulse therapy on bone mass and biochemical markers of bone metabolism in patients with active rheumatoid arthritis: a 12-month randomized prospective controlled study.
    Bruno Frediani, Paolo Falsetti, Stefania Bisogno, Fabio Baldi, Caterina Acciai, Georgios Filippou, Maria Romana Bacarelli, Paolo Filipponi, Mauro Galeazzi and Roberto Marcolongo
    The Journal of Rheumatology June 1 2004, 31 (6) 1083-1087;
  • You have access
    Progression of rheumatoid arthritis on plain radiographs judged differently by expert radiologists and rheumatologists.
    Karin Bruynesteyn, Sjef Van Der Linden, Robert Landewé, Feikje Gubler, René Weijers and Désirée Van Der Heijde
    The Journal of Rheumatology June 1 2004, 31 (6) 1088-1094;
  • You have access
    High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis.
    Patrick H Dessein, Barry I Joffe and Anne E Stanwix
    The Journal of Rheumatology June 1 2004, 31 (6) 1095-1097;
  • You have access
    The efficacy of switching from etanercept to infliximab in patients with rheumatoid arthritis.
    Karen E Hansen, Julie P Hildebrand, Mark C Genovese, John J Cush, Supen Patel, David A Cooley, Stanley B Cohen, Ronald E Gangnon and Michael H Schiff
    The Journal of Rheumatology June 1 2004, 31 (6) 1098-1102;
  • You have access
    Effects of anakinra monotherapy on joint damage in patients with rheumatoid arthritis. Extension of a 24-week randomized, placebo-controlled trial.
    Barry Bresnihan, Richard Newmark, Sean Robbins and Harry K Genant
    The Journal of Rheumatology June 1 2004, 31 (6) 1103-1111;
  • You have access
    Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis.
    Koichi Yanaba, Minoru Hasegawa, Kazuhiko Takehara and Shinichi Sato
    The Journal of Rheumatology June 1 2004, 31 (6) 1112-1120;
  • You have access
    Centromere protein C is a target of autoantibodies in Sjögren's syndrome and is uniformly associated with antibodies to Ro and La.
    Stanley R Pillemer, Livia Casciola-Rosen, Bruce J Baum, Antony Rosen and Allan C Gelber
    The Journal of Rheumatology June 1 2004, 31 (6) 1121-1125;
  • You have access
    The clinical assessment of patients with psoriatic arthritis: results of a reliability study of the spondyloarthritis research consortium of Canada.
    Dafna D Gladman, Richard J Cook, Cathy Schentag, Marie Feletar, Robert I Inman, Carol Hitchon, Jacob Karsh, Alice V Klinkhoff, Walter P Maksymowych, Dianne P Mosher, Bindu Nair and Millicent A Stone
    The Journal of Rheumatology June 1 2004, 31 (6) 1126-1131;
  • You have access
    Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.
    Masahiko Mihara, Masashi Shiina, Norihiro Nishimoto, Kazuyuki Yoshizaki, Tadamitsu Kishimoto and Ken-Ichi Akamatsu
    The Journal of Rheumatology June 1 2004, 31 (6) 1132-1138;
  • You have access
    Influence of Serum Amyloid A (SAA1) and SAA2 gene polymorphisms on renal amyloidosis, and on SAA/C-reactive protein values in patients with familial mediterranean fever in the Turkish population.
    Aysin Bakkaloglu, Ali Duzova, Seza Ozen, Banu Balci, Nesrin Besbas, Rezan Topaloglu, Fatih Ozaltin and Engin Yilmaz
    The Journal of Rheumatology June 1 2004, 31 (6) 1139-1142;
  • You have access
    Blood pressure destabilization and edema among 8538 users of celecoxib, rofecoxib, and nonselective nonsteroidal antiinflammatory drugs (NSAID) and nonusers of NSAID receiving ordinary clinical care.
    Frederick Wolfe, Sean Zhao and Dan Pettitt
    The Journal of Rheumatology June 1 2004, 31 (6) 1143-1151;
  • You have access
    Hypertension was the major risk factor leading to development of cardiovascular diseases among men with hyperuricemia.
    Kuan-Chia Lin, Hsuan-Ming Tsao, Chen-Huan Chen and Pesus Chou
    The Journal of Rheumatology June 1 2004, 31 (6) 1152-1158;
  • You have access
    Different progressions of hyperglycemia and diabetes among hyperuricemic men and women in the kinmen study.
    Kuan-Chia Lin, Shih-Tzer Tsai, Hsiao-Yi Lin and Pesus Chou
    The Journal of Rheumatology June 1 2004, 31 (6) 1159-1165;
  • You have access
    The effect of a preoperative exercise and education program on functional recovery, health related quality of life, and health service utilization following primary total knee arthroplasty.
    Lauren A Beaupre, Doug Lier, Donna M Davies and D Bill C Johnston
    The Journal of Rheumatology June 1 2004, 31 (6) 1166-1173;
  • You have access
    Cartilage destruction in collagen induced arthritis assessed with a new biochemical marker for collagen type II C-telopeptide fragments.
    Takeshi Ishikawa, Fusako Nishigaki, Stephan Christgau, Takahisa Noto, John Mo, Niels From, Kyoko Minoura, Yoshitaka Hirayama, Yoshitaka Ohkubo and Seitaro Mutoh
    The Journal of Rheumatology June 1 2004, 31 (6) 1174-1179;
  • You have access
    The comprehensive osteoarthritis test: a simple index for measurement of treatment effects in clinical trials.
    Lyndon O Brooks, Margaret I Rolfe, Phillip A Cheras and Stephen P Myers
    The Journal of Rheumatology June 1 2004, 31 (6) 1180-1186;
  • You have access
    Important determinants of self-efficacy in patients with chronic musculoskeletal pain.
    Anisur Rahman, Gareth Ambler, Martin R Underwood and Michael E Shipley
    The Journal of Rheumatology June 1 2004, 31 (6) 1187-1192;
  • You have access
    Cyclic alternating pattern: a new marker of sleep alteration in patients with fibromyalgia?
    Maurizio Rizzi, Piercarlo Sarzi-Puttini, Fabiola Atzeni, Franco Capsoni, Arnaldo Andreoli, Marica Pecis, Stefano Colombo, Mario Carrabba and Margherita Sergi
    The Journal of Rheumatology June 1 2004, 31 (6) 1193-1199;
  • You have access
    Physician resources and postgraduate training in canadian academic rheumatology centers: a 5-year prospective study.
    John G Hanly
    The Journal of Rheumatology June 1 2004, 31 (6) 1200-1205;
  • You have access
    Association of single nucleotide polymorphisms within cytokine genes with juvenile idiopathic arthritis in the Czech population.
    Ondrej Cinek, Pavla Vavrincová, Ilja Striz, Pavel Drevínek, Pavlína Sedláková, Jan Vavrinec and Antonij Slavcev
    The Journal of Rheumatology June 1 2004, 31 (6) 1206-1210;
  • You have access
    Antiagalactosyl IgG antibodies in juvenile idiopathic arthritis, juvenile onset Sjögren's syndrome, and healthy children.
    Nobuaki Maeno, Syuji Takei, Satoshi Fujikawa, Yuji Yamada, Hiroyuki Imanaka, Masashi Hokonohara, Yoshifumi Kawano and Hiroshi Oda
    The Journal of Rheumatology June 1 2004, 31 (6) 1211-1217;
  • You have access
    Vasopressin cell antibodies and central diabetes insipidus in a patient with systemic lupus erythematosus and dermatomyositis.
    Hiroshi Kajiyama, Chihiro Terai, Annamaria De Bellis, Antonio Bizzarro, Antonio Bellastella, Shuji Ohta, Hiroshi Okamoto, Masashi Uesato, Masako Hara and Naoyuki Kamatani
    The Journal of Rheumatology June 1 2004, 31 (6) 1218-1221;
  • You have access
    Identity loss due to chronic fingertip ischemia.
    Jose C Crispin, Margarita Fallena and Arnoldo Kraus
    The Journal of Rheumatology June 1 2004, 31 (6) 1222-1224;
  • You have access
    Diagnosis and followup of Takayasu's arteritis by scintigraphy with radiolabelled interleukin 2.
    Piernatale Lucia, Maria Gemma Parisella, Chiara Danese, Flaminia Bruno, Luca Luigi Manetti, Gabriela Capriotti, Carlo De Martinis, Francesco Scopinaro, Maria Alessandra Perego and Alberto Signore
    The Journal of Rheumatology June 1 2004, 31 (6) 1225-1227;
  • You have access
    Dose-dependent severe arthralgia induced by gabapentin.
    Abdulaziz Almahrezi and Mary-Ann Fitzcharles
    The Journal of Rheumatology June 1 2004, 31 (6) 1228;
Back to top
PreviousNext

In this issue

The Journal of Rheumatology
Vol. 31, Issue 6
1 Jun 2004
  • Table of Contents
  • Index by Author
  • Most Read
  • ​ Editor's Picks
  • E-letters
Loading
  • Effects of Bedtime Very Low Dose Cyclobenzaprine on Symptoms and Sleep Physiology in Patients with Fibromyalgia Syndrome: A Double-blind Randomized Placebo-controlled Study
  • Management of Calcinosis Cutis in Rheumatic Diseases
  • Scleroderma-like Disease Due to Diffuse Monosodium Urate Crystal Deposition
  • Long-Term Safety and Efficacy of Ixekizumab in Patients With Axial Spondyloarthritis: 3-year Data From the COAST Program
  • Rat Bite Erosion of the Knee
More...

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire